LOMITAPIDE
Tracking # 20-1014786
$99999.00
There are no ratings for this course
Learn more Educator STATPEARLS PUBLISHING, LLC
CE Broker Reporting Reported automatically
Method Computer-Based Training
Course overview
HOMOZYGOUS FAMILIAL HYPERCHOLESTEROLEMIA (HOFH) MEDICATIONS COMPRISE MIPOMERSEN AND LOMITAPIDE. LOMITAPIDE IS AN FDA-APPROVED IN ADDITION TO A DIET LOW IN FATS, AND OTHER DRUGS USED TO REDUCE LIPIDS, TO DECREASE LOW-DENSITY LIPOPROTEIN (LDL) CHOLESTEROL, APOLIPOPROTEIN B, AND OTHER LIPOPROTEINS, IN PATIENTS SUFFERING FROM HOFH.
Subject areas
This course counts toward the state boards and subject areas below.
Arkansas State Board of Nursing
Certified Nurse Midwife
1h
Practice-Focused Continuing Education
Certified Nurse Practitioner
1h
Practice-Focused Continuing Education
Certified Registered Nurse Anesthetist
1h
Practice-Focused Continuing Education
Clinical Nurse Specialist
1h
Practice-Focused Continuing Education
Licensed Practical Nurse
1h
Practice-Focused Continuing Education
Licensed Psychiatric Technician Nurse
1h
Practice-Focused Continuing Education
Registered Nurse
1h
Practice-Focused Continuing Education
Registered Nurse Practitioner
1h
Practice-Focused Continuing Education
District of Columbia Board of Nursing
Licensed Practical Nurse
1h
Licensed Practical Nurse - Continuing Education
Registered Nurse
1h
Pharmacology Component
Georgia Board of Nursing
Licensed Practical Nurse
1h
General
Registered Professional Nurse
1h
General
South Carolina Board of Nursing
Advanced Practice Registered Nurse
1h
Pharmacotherapeutics
Licensed Practical Nurse
1h
Pharmacotherapeutics
Registered Nurse
1h
Pharmacotherapeutics
West Virginia Board of Registered Nurses
Advanced Practice Registered Nurse
1h
Relating to professional nursing practice